-
My Account
In App
My Account
BSE Live
Jan 23, 16:01Prev. Close
201.30
Open Price
203.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:53Prev. Close
193.98
Open Price
204.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
207.16 (2141)
| Cash Flow of Viyash Scientific (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 22.81 | 6.20 | 409.27 | -0.01 | 7.15 | |
| Net CashFlow From Operating Activities | 30.20 | 73.80 | -4.34 | -24.04 | 100.02 | |
| Net Cash Used In Investing Activities | -10.39 | -114.06 | 15.93 | -46.84 | -359.41 | |
| Net Cash Used From Financing Activities | -18.01 | 40.34 | -11.78 | 70.97 | 247.38 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 1.81 | 0.07 | -0.19 | 0.09 | -12.01 | |
| Cash And Cash Equivalents Begin of Year | 1.07 | 1.00 | 1.19 | 1.10 | 13.10 | |
| Cash And Cash Equivalents End Of Year | 2.87 | 1.07 | 1.00 | 1.19 | 1.09 |
02.12.2025
Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y
22.08.2025
Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y
21.05.2025
Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y
24.02.2025
Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y
